KRAS and gastric cancer: The results obtained from the studies mentioned above not only identified GC-related alterations in a number of oncogenes, such as KRAS (Till et al., 2017), c-MET (Bradley et al., 2017), and c-Myc (Khanna et al., 2009), but also revealed the complicated relationship that govern GC malignant progression.